PTCHF
PureTech Health plc
Price Chart
Latest Quote
$1.70
+0.00 (+0.00%)
Current Price
| Previous Close | $1.70 |
| Open | $1.80 |
| Day High | $1.80 |
| Day Low | $1.80 |
| Volume | 4,860 |
Stock Information
| Shares Outstanding | 243.42M |
| Total Debt | $203.26M |
| Cash Equivalents | $288.72M |
| Revenue | $4.66M |
| Net Income | $-109.74M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $413.81M |
| EPS (TTM) | $-0.46 |
| Exchange | PNK |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $321.95M |
| Sales | $4.66M |
| Income | $-109.74M |
| Book/sh | $1.29 |
| Cash/sh | $1.19 |
| Employees | 90 |
Financial Ratios
| Quick Ratio | 6.41 |
| Current Ratio | 6.59 |
| Debt/Eq | 66.49 |
Returns & Margins
| ROA | -10.82% |
| ROE | -30.85% |
| Operating Margin | -1797.79% |
Ownership
| Insider Ownership | 9.86% |
| Institutional Ownership | 55.73% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 88.82 |
| P/B | 1.32 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $1.79 |
| SMA50 | $1.75 |
| SMA200 | $1.69 |
| ATR | 0.0116 |
| Shares Float | 157.41M |
| Volatility | 0.81 |
Performance History
| Week | +0.00% |
| Month | +0.59% |
| Quarter | +9.68% |
| 6 Months | +9.68% |
| YTD | -0.29% |
| Year | -2.86% |
| 3 Years | -43.24% |
| 5 Years | -67.68% |
| 10 Years | -12.37% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $1.70 | 0 |
| 2026-06-17 | $1.70 | 0 |
| 2026-06-16 | $1.70 | 0 |
| 2026-06-15 | $1.70 | 0 |
| 2026-06-12 | $1.70 | 0 |
| 2026-06-11 | $1.70 | 500 |
| 2026-06-10 | $1.86 | 0 |
| 2026-06-09 | $1.86 | 0 |
| 2026-06-08 | $1.86 | 0 |
| 2026-06-05 | $1.86 | 0 |
| 2026-06-04 | $1.86 | 0 |
| 2026-06-03 | $1.86 | 0 |
| 2026-06-02 | $1.86 | 0 |
| 2026-06-01 | $1.86 | 0 |
| 2026-05-29 | $1.86 | 0 |
| 2026-05-28 | $1.86 | 0 |
| 2026-05-27 | $1.86 | 0 |
| 2026-05-26 | $1.86 | 3,500 |
| 2026-05-22 | $1.65 | 0 |
| 2026-05-21 | $1.65 | 89,000 |
| 2026-05-20 | $1.69 | 0 |
| 2026-05-19 | $1.69 | 0 |
About PureTech Health plc
PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. It is developing LYT-100, a Phase 3-ready therapeutic candidate with the potential to establish a new standard of care (SOC) for the treatment of idiopathic pulmonary fibrosis (IPF) and other fibrotic lung diseases and LYT-200, a fully human IgG4 monoclonal antibody. The company also develops SPT-300, a Glyphed oral prodrug of allopregnanolone for the treatment of anxious depression; and delivers transformative medicines for patients with psychiatric and neurological conditions. In addition, the company develops hydrogels to enable the oral administration of peptide therapeutics in preclinical development and oral therapies based on defined bacterial consortia that is in phase 3 clinical stage. PureTech Health plc was incorporated in 2015 and is based in Boston, Massachusetts.
đ° Latest News
Seaport Therapeutics stock pops 17% on Nasdaq debut
Quartz âĸ 2026-05-01T17:32:35Z
PureTech Health shares boosted as investee Seaport Therapeutics prices Nasdaq IPO
Proactive âĸ 2026-05-01T08:26:00Z
PureTech Health H2 Earnings Call Highlights
MarketBeat âĸ 2026-04-29T20:30:27Z
PureTech Health plc (LON:PRTC) is favoured by institutional owners who hold 73% of the company
Simply Wall St. âĸ 2026-01-03T09:18:34Z
PureTech Health Completes End-of-Phase 2 Meeting With FDA for Deupirfenidone to Treat Idiopathic Pulmonary Fibrosis
MT Newswires âĸ 2025-12-08T10:13:49ZWhat Makes PureTech Health (PRTC) a New Buy Stock
Zacks âĸ 2025-09-16T16:00:03Z
PureTech forms respiratory spin-off Celea to advance deuterated pirfenidone
Pharmaceutical Technology âĸ 2025-08-13T11:46:39Z
PureTech launches new biotech built around lung disease drug
BioPharma Dive âĸ 2025-08-12T12:22:00Z
With 71% ownership of the shares, PureTech Health plc (LON:PRTC) is heavily dominated by institutional owners
Simply Wall St. âĸ 2025-07-27T08:31:13Z
Vor, with new CEO, changes course to target autoimmune disease
BioPharma Dive âĸ 2025-06-26T15:22:00Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $4,315,000 | $750,000 | $2,090,000 | $9,979,000 |
| Operating Revenue | $4,315,000 | $750,000 | $2,090,000 | $9,979,000 |
| Expenses | ||||
| Interest Expense | $10,037,000 | $13,488,000 | $3,953,000 | $4,714,000 |
| Total Expenses | $140,410,000 | $146,951,000 | $199,896,000 | $160,263,000 |
| Other Non Operating Income Expenses | $961,000 | $-908,000 | $8,131,000 | $1,592,000 |
| Net Non Operating Interest Income Expense | $12,632,000 | $2,524,000 | $1,846,000 | $-4,500,000 |
| Interest Expense Non Operating | $10,037,000 | $13,488,000 | $3,953,000 | $4,714,000 |
| Operating Expense | $140,410,000 | $146,951,000 | $199,896,000 | $160,263,000 |
| Other Operating Expenses | $3,699,000 | $4,189,000 | $5,194,000 | $4,647,000 |
| General And Administrative Expense | $27,491,000 | $25,180,000 | $31,600,000 | $26,714,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $53,510,000 | $-65,697,000 | $-50,354,000 | $-60,558,000 |
| Net Interest Income | $12,632,000 | $2,524,000 | $1,846,000 | $-4,500,000 |
| Interest Income | $22,669,000 | $16,012,000 | $5,799,000 | $214,000 |
| Normalized Income | $-58,610,750 | $-178,082,400 | $-147,350,990 | $-183,195,810 |
| Net Income From Continuing And Discontinued Operation | $53,510,000 | $-65,697,000 | $-50,354,000 | $-60,558,000 |
| Total Operating Income As Reported | $-136,095,000 | $-146,199,000 | $-197,807,000 | $-150,282,000 |
| Net Income Common Stockholders | $53,510,000 | $-65,697,000 | $-50,354,000 | $-60,558,000 |
| Net Income | $53,510,000 | $-65,697,000 | $-50,354,000 | $-60,558,000 |
| Net Income Including Noncontrolling Interests | $27,782,000 | $-66,628,000 | $-37,065,000 | $-62,709,000 |
| Net Income Continuous Operations | $27,782,000 | $-66,628,000 | $-37,065,000 | $-62,709,000 |
| Pretax Income | $23,774,000 | $-36,103,000 | $-92,783,000 | $-58,953,000 |
| Special Income Charges | $152,280,000 | $61,787,000 | $47,081,000 | $0 |
| Interest Income Non Operating | $22,669,000 | $16,012,000 | $5,799,000 | $214,000 |
| Operating Income | $-136,095,000 | $-146,201,000 | $-197,806,000 | $-150,284,000 |
| Depreciation And Amortization In Income Statement | $3,571,000 | $4,934,000 | $8,893,000 | $7,287,000 |
| Depreciation Income Statement | $1,807,000 | $2,955,000 | $5,845,000 | $4,347,000 |
| Per Share | ||||
| Diluted EPS | $0.21 | $-0.24 | $-0.18 | $-0.21 |
| Basic EPS | $0.21 | $-0.24 | $-0.18 | $-0.21 |
| Other | ||||
| Tax Effect Of Unusual Items | $29,804,250 | $29,874,600 | $25,784,010 | $45,359,190 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-104,543,000 | $-159,941,000 | $-202,718,000 | $-214,949,000 |
| Total Unusual Items | $141,925,000 | $142,260,000 | $122,781,000 | $167,997,000 |
| Total Unusual Items Excluding Goodwill | $141,925,000 | $142,260,000 | $122,781,000 | $167,997,000 |
| Reconciled Depreciation | $3,571,000 | $4,933,000 | $8,893,000 | $7,287,000 |
| EBITDA (Bullshit earnings) | $37,382,000 | $-17,681,000 | $-79,937,000 | $-46,952,000 |
| EBIT | $33,811,000 | $-22,615,000 | $-88,830,000 | $-54,239,000 |
| Diluted Average Shares | $256,027,920 | $276,302,533 | $284,759,435 | $286,590,983 |
| Basic Average Shares | $254,456,308 | $276,302,533 | $284,759,435 | $286,590,983 |
| Diluted NI Availto Com Stockholders | $53,510,000 | $-65,697,000 | $-50,354,000 | $-60,558,000 |
| Otherunder Preferred Stock Dividend | $0 | $0 | $0 | $0 |
| Minority Interests | $25,728,000 | $931,000 | $-13,290,000 | $2,151,000 |
| Tax Provision | $-4,008,000 | $30,525,000 | $-55,719,000 | $3,756,000 |
| Other Special Charges | $-152,280,000 | $-61,787,000 | $-55,471,000 | $53,000 |
| Write Off | $0 | $0 | $8,390,000 | $0 |
| Amortization | $1,764,000 | $1,979,000 | $3,048,000 | $2,940,000 |
| Research And Development | $54,280,000 | $73,729,000 | $111,288,000 | $78,282,000 |
| Selling General And Administration | $27,491,000 | $25,180,000 | $31,600,000 | $26,714,000 |
| Impairment Of Capital Assets | - | - | - | $0 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $414,106,000 | $463,160,000 | $541,389,000 | $592,528,000 |
| Total Assets | $602,635,000 | $693,973,000 | $702,647,000 | $946,006,000 |
| Total Non Current Assets | $216,379,000 | $346,771,000 | $316,454,000 | $444,197,000 |
| Other Non Current Assets | $476,000 | $878,000 | $10,000 | $810,000 |
| Investmentin Financial Assets | $191,426,000 | $317,841,000 | $251,892,000 | $397,179,000 |
| Financial Assets Designatedas Fair Value Through Profitor Loss Total | $191,426,000 | $317,841,000 | $251,892,000 | $397,179,000 |
| Goodwill And Other Intangible Assets | $601,000 | $906,000 | $831,000 | $987,000 |
| Other Intangible Assets | $601,000 | $906,000 | $831,000 | $987,000 |
| Current Assets | $386,256,000 | $347,201,000 | $386,192,000 | $501,809,000 |
| Restricted Cash | $1,642,000 | $1,628,000 | $2,124,000 | $2,124,000 |
| Prepaid Assets | $4,404,000 | $4,309,000 | $11,617,000 | $10,755,000 |
| Other Receivables | $11,381,000 | - | - | $15,120,000 |
| Taxes Receivable | $0 | $11,746,000 | $10,040,000 | $4,514,000 |
| Accounts Receivable | $1,522,000 | $2,376,000 | $11,867,000 | $3,174,000 |
| Cash Cash Equivalents And Short Term Investments | $367,307,000 | $327,143,000 | $350,095,000 | $465,708,000 |
| Cash And Cash Equivalents | $280,641,000 | $191,081,000 | $149,866,000 | $465,708,000 |
| Other Current Assets | - | $-1,000 | $-1,000 | $-1,000 |
| Debt | ||||
| Total Debt | $22,361,000 | $25,343,000 | $46,872,000 | $52,749,000 |
| Long Term Debt And Capital Lease Obligation | $14,671,000 | $18,250,000 | $34,399,000 | $43,301,000 |
| Current Debt And Capital Lease Obligation | $7,690,000 | $7,093,000 | $12,473,000 | $9,448,000 |
| Current Debt | $4,111,000 | $3,699,000 | $7,501,000 | $5,498,000 |
| Long Term Debt | - | $0 | $10,244,000 | $14,261,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $194,702,000 | $235,742,000 | $155,058,000 | $361,859,000 |
| Total Non Current Liabilities Net Minority Interest | $153,314,000 | $184,372,000 | $58,173,000 | $135,724,000 |
| Other Non Current Liabilities | $136,782,000 | $110,159,000 | $1,000 | $-1,000 |
| Non Current Deferred Taxes Liabilities | $0 | $52,462,000 | $19,645,000 | $89,765,000 |
| Current Liabilities | $41,388,000 | $51,370,000 | $96,885,000 | $226,135,000 |
| Other Current Liabilities | $6,604,000 | $169,000 | $27,339,000 | $174,017,000 |
| Payables | $6,514,000 | $14,640,000 | $28,518,000 | $13,806,000 |
| Other Payable | $917,000 | $3,000 | $1,957,000 | $2,403,000 |
| Total Tax Payable | $75,000 | $0 | $57,000 | $57,000 |
| Accounts Payable | $5,522,000 | $14,637,000 | $26,504,000 | $11,346,000 |
| Equity | ||||
| Common Stock Equity | $414,707,000 | $464,066,000 | $542,220,000 | $593,515,000 |
| Total Equity Gross Minority Interest | $407,933,000 | $458,231,000 | $547,589,000 | $584,147,000 |
| Stockholders Equity | $414,707,000 | $464,066,000 | $542,220,000 | $593,515,000 |
| Other Equity Interest | $1,000 | $-1,000 | - | $-1,000 |
| Retained Earnings | $32,486,000 | $83,820,000 | $149,516,000 | $199,871,000 |
| Long Term Equity Investment | $2,397,000 | $3,185,000 | $9,147,000 | $0 |
| Other | ||||
| Treasury Shares Number | $18,506,177 | $17,614,428 | $10,595,347 | - |
| Ordinary Shares Number | $239,421,312 | $271,853,731 | $278,566,306 | $287,796,585 |
| Share Issued | $257,927,489 | $289,468,159 | $289,161,653 | $287,796,585 |
| Tangible Book Value | $414,106,000 | $463,160,000 | $541,389,000 | $592,528,000 |
| Invested Capital | $418,818,000 | $467,765,000 | $559,965,000 | $613,274,000 |
| Working Capital | $344,868,000 | $295,831,000 | $289,307,000 | $275,674,000 |
| Capital Lease Obligations | $18,250,000 | $21,644,000 | $29,127,000 | $32,990,000 |
| Total Capitalization | $414,707,000 | $464,066,000 | $552,464,000 | $607,776,000 |
| Minority Interest | $-6,774,000 | $-5,835,000 | $5,369,000 | $-9,368,000 |
| Treasury Stock | $46,864,000 | $44,626,000 | $26,492,000 | $0 |
| Additional Paid In Capital | $290,262,000 | $290,262,000 | $289,624,000 | $289,303,000 |
| Capital Stock | $4,860,000 | $5,461,000 | $5,455,000 | $5,444,000 |
| Common Stock | $4,860,000 | $5,461,000 | $5,455,000 | $5,444,000 |
| Non Current Pension And Other Postretirement Benefit Plans | $1,861,000 | $3,501,000 | $4,128,000 | $2,659,000 |
| Long Term Capital Lease Obligation | $14,671,000 | $18,250,000 | $24,155,000 | $29,040,000 |
| Current Capital Lease Obligation | $3,579,000 | $3,394,000 | $4,972,000 | $3,950,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $1,875,000 | $1,281,000 | $1,805,000 | $4,703,000 |
| Available For Sale Securities | $191,426,000 | $317,841,000 | $251,892,000 | $397,179,000 |
| Investmentsin Associatesat Cost | $2,397,000 | $3,185,000 | $9,147,000 | $0 |
| Net PPE | $15,129,000 | $19,361,000 | $37,238,000 | $43,936,000 |
| Accumulated Depreciation | $-12,847,000 | $-12,982,000 | $-20,080,000 | $-14,345,000 |
| Gross PPE | $27,976,000 | $32,343,000 | $57,318,000 | $58,281,000 |
| Construction In Progress | $0 | $1,000 | $2,803,000 | $8,116,000 |
| Other Properties | $11,209,000 | $15,188,000 | $27,622,000 | $28,899,000 |
| Machinery Furniture Equipment | $1,602,000 | $1,989,000 | $2,929,000 | $2,781,000 |
| Buildings And Improvements | $15,165,000 | $15,165,000 | $23,964,000 | $18,485,000 |
| Properties | $0 | $0 | $0 | $0 |
| Other Short Term Investments | $86,666,000 | $136,062,000 | $200,229,000 | - |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-134,380,000 | $-106,162,000 | $-180,968,000 | $-163,935,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-134,369,000 | $-105,917,000 | $-178,792,000 | $-158,274,000 |
| Investing Activities | ||||
| Capital Expenditure | $-11,000 | $-245,000 | $-2,176,000 | $-5,661,000 |
| Investing Cash Flow | $240,888,000 | $68,991,000 | $-107,223,000 | $197,375,000 |
| Net Other Investing Changes | - | - | $416,000 | $381,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-107,559,000 | $-19,650,000 | $-26,492,000 | $0 |
| Issuance Of Capital Stock | $895,000 | $1,153,000 | $332,000 | $-12,979,000 |
| Financing Cash Flow | $-16,958,000 | $78,141,000 | $-29,827,000 | $22,727,000 |
| Net Other Financing Charges | $93,100,000 | $99,976,000 | $-35,000 | $36,866,000 |
| Net Common Stock Issuance | $-106,664,000 | $-18,497,000 | $-26,160,000 | $-12,979,000 |
| Common Stock Issuance | $895,000 | $1,153,000 | $332,000 | $-12,979,000 |
| Other | ||||
| Issuance Of Debt | $0 | $0 | $393,000 | $2,215,000 |
| End Cash Position | $280,641,000 | $191,081,000 | $149,866,000 | $465,708,000 |
| Other Cash Adjustment Outside Changein Cash | $-1,000 | - | - | $-1,000 |
| Beginning Cash Position | $191,081,000 | $149,866,000 | $465,708,000 | $403,881,000 |
| Changes In Cash | $89,561,000 | $41,215,000 | $-315,842,000 | $61,828,000 |
| Common Stock Payments | $-107,559,000 | $-19,650,000 | $-26,492,000 | $0 |
| Net Issuance Payments Of Debt | $0 | $0 | $393,000 | $2,215,000 |
| Net Long Term Debt Issuance | $0 | $0 | $393,000 | $2,215,000 |
| Long Term Debt Issuance | $0 | $0 | $393,000 | $2,215,000 |
| Net Investment Purchase And Sale | $346,614,000 | $82,155,000 | $-85,023,000 | $202,625,000 |
| Sale Of Investment | $656,216,000 | $277,865,000 | $183,710,000 | $218,125,000 |
| Purchase Of Investment | $-309,602,000 | $-195,710,000 | $-268,733,000 | $-15,500,000 |
| Net Business Purchase And Sale | $-105,970,000 | $-13,784,000 | $-20,440,000 | $0 |
| Purchase Of Business | $-105,970,000 | $-13,784,000 | $-20,440,000 | $0 |
| Net Intangibles Purchase And Sale | $0 | $-175,000 | $0 | $-90,000 |
| Purchase Of Intangibles | $0 | $-175,000 | $0 | $-90,000 |
| Net PPE Purchase And Sale | $244,000 | $795,000 | $-2,176,000 | $-5,541,000 |
| Sale Of PPE | $255,000 | $865,000 | $0 | $30,000 |
| Purchase Of PPE | $-11,000 | $-70,000 | $-2,176,000 | $-5,571,000 |
| Taxes Refund Paid | $-37,913,000 | $-150,000 | $-20,696,000 | $-27,766,000 |
| Interest Received Cfo | $23,547,000 | $14,454,000 | $3,460,000 | $214,000 |
| Interest Paid Cfo | $-1,295,000 | $-1,701,000 | $-3,366,000 | $-3,382,000 |
| Change In Working Capital | $-10,236,000 | $17,519,000 | $15,919,000 | $861,000 |
| Change In Other Current Assets | $92,000 | $1,091,000 | $2,482,000 | $-1,510,000 |
| Change In Payable | $-9,695,000 | $3,844,000 | $22,033,000 | $8,338,000 |
| Change In Prepaid Assets | $-1,262,000 | $2,834,000 | $-862,000 | $-5,350,000 |
| Change In Receivables | $629,000 | $9,750,000 | $-7,734,000 | $-617,000 |
| Other Non Cash Items | $-12,632,000 | $-2,524,000 | $-1,846,000 | $4,500,000 |
| Stock Based Compensation | $22,850,000 | $4,415,000 | $14,698,000 | $13,950,000 |
| Deferred Tax | $-4,008,000 | $30,525,000 | $-55,719,000 | $3,756,000 |
| Depreciation And Amortization | $3,571,000 | $4,933,000 | $8,893,000 | $7,287,000 |
| Amortization Cash Flow | $1,764,000 | $1,979,000 | $3,048,000 | $2,940,000 |
| Depreciation | $1,807,000 | $2,954,000 | $8,893,000 | $4,347,000 |
| Gain Loss On Investment Securities | $-2,762,000 | $-52,382,000 | $-83,725,000 | $-168,744,000 |
| Net Foreign Currency Exchange Gain Loss | $25,000 | $94,000 | $-14,000 | $56,000 |
| Gain Loss On Sale Of Business | $-152,007,000 | $-61,787,000 | $-55,471,000 | $0 |
| Net Income From Continuing Operations | $27,782,000 | $-66,628,000 | $-37,065,000 | $-62,709,000 |
| Net Short Term Debt Issuance | - | $0 | $393,000 | $2,215,000 |
| Short Term Debt Issuance | - | $0 | $393,000 | $2,215,000 |
| Gain Loss On Sale Of PPE | - | - | $138,000 | $53,000 |
| Repayment Of Debt | - | - | - | $0 |
| Effect Of Exchange Rate Changes | - | - | - | $0 |
| Long Term Debt Payments | - | - | - | $0 |
| Change In Other Current Liabilities | - | - | - | $0 |
Fetched: 2026-02-02